167 related articles for article (PubMed ID: 33014844)
1. Diagnostic and Prognostic Values of Serum EpCAM, TGM2, and HE4 Levels in Endometrial Cancer.
Lan T; Mu C; Wang Z; Wang Y; Li Y; Mai Y; Li S; Xu H; Gu B; Luo L; Ma P
Front Oncol; 2020; 10():1697. PubMed ID: 33014844
[No Abstract] [Full Text] [Related]
2. Diagnostic Performance of Serum Human Epididymis Protein 4 in Endometrial Carcinoma: A Pilot Study.
Dewan R; Dewan A; Hare S; Bhardwaj M; Mehrotra K
J Clin Diagn Res; 2017 Jul; 11(7):XC01-XC05. PubMed ID: 28893024
[TBL] [Abstract][Full Text] [Related]
3. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer.
Knific T; Osredkar J; Smrkolj Š; Tonin I; Vouk K; Blejec A; Frković Grazio S; Rižner TL
Gynecol Oncol; 2017 Oct; 147(1):126-132. PubMed ID: 28735628
[TBL] [Abstract][Full Text] [Related]
4. CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis.
Torres A; Pac-Sosińska M; Wiktor K; Paszkowski T; Maciejewski R; Torres K
BMC Cancer; 2019 Apr; 19(1):401. PubMed ID: 31035965
[TBL] [Abstract][Full Text] [Related]
5. Association of preoperative serum HE4 levels on the survival of patients with endometrial cancer.
Insin P; Yimyam Y; Prueksaritanond N
Arch Gynecol Obstet; 2021 Nov; 304(5):1335-1343. PubMed ID: 34109467
[TBL] [Abstract][Full Text] [Related]
6. Association of Serum HE4 with Primary Tumor Diameter and Depth of Myometrial Invasion in Endometrial Cancer Patients at Rajavithi Hospital.
Prueksaritanond N; Cheanpracha P; Yanaranop M
Asian Pac J Cancer Prev; 2016; 17(3):1489-92. PubMed ID: 27039795
[TBL] [Abstract][Full Text] [Related]
7. Combination of serum CST1 and HE4 for early diagnosis of endometrial cancer.
Zhong W; Liu Y; Zhang L; Zhuang W; Chen J; Huang Z; Zheng Y; Huang Y
PeerJ; 2023; 11():e16424. PubMed ID: 38077439
[TBL] [Abstract][Full Text] [Related]
8. Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.
Stiekema A; Lok C; Korse CM; van Driel WJ; van der Noort V; Kenter GG; Van de Vijver KK
Virchows Arch; 2017 Jun; 470(6):655-664. PubMed ID: 28401338
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values of human epididymis protein 4 expression in patients with endometrial cancer: A systematic review and meta-analysis.
Han LN; Han YW; Yan P
J Obstet Gynaecol Res; 2022 Sep; 48(9):2255-2269. PubMed ID: 35844088
[TBL] [Abstract][Full Text] [Related]
10. Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients.
Cymbaluk-Płoska A; Chudecka-Głaz A; Pius-Sadowska E; Sompolska-Rzechuła A; Machaliński B; Surowiec A; Menkiszak J
Onco Targets Ther; 2017; 10():3169-3175. PubMed ID: 28721066
[TBL] [Abstract][Full Text] [Related]
11. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma].
Zhang AM; Zhang P
Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer.
Kemik P; Saatli B; Yıldırım N; Kemik VD; Deveci B; Terek MC; Koçtürk S; Koyuncuoğlu M; Saygılı U
Gynecol Oncol; 2016 Jan; 140(1):64-9. PubMed ID: 26607777
[TBL] [Abstract][Full Text] [Related]
13. Serum human epididymis protein 4 vs. carbohydrate antigen 125 and their combination for endometrial cancer diagnosis: a meta-analysis.
Chen Y; Ren YL; Li N; Yi XF; Wang HY
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):1974-85. PubMed ID: 27249595
[TBL] [Abstract][Full Text] [Related]
14. Serum HE4 as a prognostic marker in endometrial cancer--a population based study.
Brennan DJ; Hackethal A; Metcalf AM; Coward J; Ferguson K; Oehler MK; Quinn MA; Janda M; Leung Y; Freemantle M; ; Webb PM; Spurdle AB; Obermair A
Gynecol Oncol; 2014 Jan; 132(1):159-65. PubMed ID: 24211402
[TBL] [Abstract][Full Text] [Related]
15. Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer.
Chovanec J; Selingerova I; Greplova K; Antonsen SL; Nalezinska M; Høgdall C; Høgdall E; Søgaard-Andersen E; Jochumsen KM; Fabian P; Valik D; Zdrazilova-Dubska L
Oncotarget; 2017 Dec; 8(64):108213-108222. PubMed ID: 29296235
[TBL] [Abstract][Full Text] [Related]
16. Function of homocysteine and HE4 in endometrial carcinoma: verified by prospective experiment.
Yang Z; Zhou J; Wu J; Liu G; Xi Q
Transl Cancer Res; 2024 Feb; 13(2):634-643. PubMed ID: 38482446
[TBL] [Abstract][Full Text] [Related]
17. Preoperative markers for the prediction of high-risk features in endometrial cancer.
Panyavaranant P; Manchana T
World J Clin Oncol; 2020 Jun; 11(6):378-388. PubMed ID: 32874951
[TBL] [Abstract][Full Text] [Related]
18. HE4 as a Biomarker for Endometrial Cancer.
Behrouzi R; Barr CE; Crosbie EJ
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638250
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
Bian J; Sun X; Li B; Ming L
Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
[TBL] [Abstract][Full Text] [Related]
20. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
